Shadow World

Impulsive: 4. Big Pharma, Big Secret

Feb 13, 2026
A reporter chases whistleblowers and leaked internal documents from a major pharma firm. Stories of patients developing extreme impulse control problems after taking dopamine agonist drugs are recounted. The investigation reveals a years‑long gap between company knowledge and public warnings. Legal battles and personal fallout from undisclosed side effects are explored.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
ANECDOTE

Family Devastated By Medication-Driven Scam

  • Freddie describes his father Bill becoming reckless, using pornography and losing £300,000 to a romance scam after being prescribed a dopamine agonist.
  • Bill continued sending money and was manipulated by professional scammers, leaving Freddie to try to stop further harm.
INSIGHT

Early Internal Report Predated Public Warnings

  • Noel obtained a 2003 GSK internal report linking Rapinarol to increased libido, including cases of sexual assault and deviant sexual behaviour.
  • The report recommended adding the symptom to side effects years before patient leaflets warned about impulse control disorders.
ANECDOTE

Hypersexuality Reversed By Stopping Medication

  • Steve hid hypersexual spending and cam-girl bills from his wife while on Rapinarol and only confessed after being confronted by his Parkinson's nurse.
  • Stopping the drug produced an immediate 'light switch' effect and the compulsion vanished for him.
Get the Snipd Podcast app to discover more snips from this episode
Get the app